BiOligo have a comprehensive product and service portfolio across key R&D stages such as gene interference, gene editing, gene expression, and nucleic acid drug delivery.
Our flagship products: Our full-length gRNA kits, based on a professional large-scale synthesis platform, ensure high batch-to-batch consistency (CV <0.44%) and stability, ideal for large-scale and high-throughput library screening.



Guided by first principles thinking and lean six sigma management
查看详情

Our flagship product, the SQ series probes, is known for its exceptional sensitivity and high signal-to-noise ratio (SNR), capable of detecting as few as one copy while maintaining low background fluorescence. The RQ and RQP series probes enhance melting curve analysis, outperforming traditional TaqMan-based PCR methods, thus raising the standard in PCR detection. Our single-stranded DNA (ssDNA) library preparation kit is designed for degraded DNA, ssDNA, or mixed ssDNA and double-stranded DNA (dsDNA), with a template input range from 10 pg to 200 ng. More >
Advancing Biotech Excellence for a Healthier Future.
Founded in 2011, BiOligo Biotechnology (Shanghai) Co., Ltd. is a leading biotech manufacturer dedicated to the R&D of essential raw materials for IVD and gene therapy solutions. Embracing a Lean Six Sigma management approach, Bioligo focuses on pioneering technological advances as well as product innovation.
Historically, large-scale production in the IVD and gene therapy sectors has faced significant challenges due to inconsistency and instability in raw material quality. BiOligo has successfully addressed these critical concerns for its industrial clients, setting new standards in the field and supported the development of advanced, innovative diagnostic/pharmaceutical products.
NEWS CENTER